title: Why we may abandon basal follicle-stimulating hormone testing: a sea change in determining ovarian reserve using antimüllerian hormone.
abstract: Antimüllerian hormone is the most informative serum marker of ovarian reserve currently available and should be considered an important part of any contemporary reproductive medicine practice. It is both more convenient and informative than basal FSH and can be assessed at any point in the cycle. It is the most useful serum method of determining ovarian reserve, which guides pretreatment counseling, choice of infertility treatment, and avoidance of ovarian hyperstimulation. The future role of basal FSH testing is in doubt.
authors.affiliation: Atlanta Center for Reproductive Medicine, Atlanta, Georgia 30328, USA. jim.toner@acrm.com
authors.forename: James P
authors.initials: JP
authors.lastname: Toner
authors.forename: David B
authors.initials: DB
authors.lastname: Seifer
mesh_terms: D054304:Anti-Mullerian Hormone / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D005260:Female; D043373:Follicle Stimulating Hormone, Human / Q000097:blood*; D006801:Humans; D007247:Infertility, Female / Q000097:blood / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy; D010053:Ovary / Q000378:metabolism* / Q000503:physiopathology; D018579:Patient Selection; D011237:Predictive Value of Tests; D011379:Prognosis; D027724:Reproductive Techniques, Assisted
chemical_list: D015415:Biomarkers; D043373:Follicle Stimulating Hormone, Human; D054304:Anti-Mullerian Hormone